Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros

Métodos Terapêuticos e Terapias MTCI
Base de dados
País/Região como assunto
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Sci Rep ; 6: 36027, 2016 10 27.
Artigo em Inglês | MEDLINE | ID: mdl-27786274

RESUMO

The use of endangered animal products in traditional Chinese medicine (TCM) and other ethno-medicines is culturally widespread across many regions of Asia. In the present study, traditional efficacies of seven types of animal horn including antipyretic, sedative and procoagulant activities were evaluated. Shotgun proteomic analysis was performed on material from horns following separation into soluble and insoluble fractions. Over 200 proteins were identified in each sample using nano LC-MS/MS, and these were classified according to their molecular function and cellular component using principal component analysis (PCA). The results indicated that seven horns showed antipyretic, sedative and procoagulant effect. Proteomic analysis showed that YH and WBH were similar to RH in terms of protein profile, and GH was similar to SAH. In addition, YH and GH were similar to RH in their cellular component classification profile. PCA based on the composition of keratin and keratin-associated proteins showed that constituents of WBH and GH were similar to RH and SAH, respectively. This is the first analysis of the protein content of animal horns used in TCM, and it is effective to substitute the horn of endangered animals with sustainable alternatives from domestic animals.


Assuntos
Fatores Biológicos/análise , Fatores Biológicos/farmacologia , Cornos/química , Proteoma/análise , Animais , Antipiréticos/análise , Antipiréticos/farmacologia , Ásia , Cromatografia Líquida , Coagulantes/análise , Coagulantes/farmacologia , Hipnóticos e Sedativos/análise , Hipnóticos e Sedativos/farmacologia , Proteômica , Espectrometria de Massas em Tandem
2.
Thromb Res ; 139: 102-10, 2016 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-26916304

RESUMO

INTRODUCTION: Coagulation factor concentrates like factor IX (FIX) and prothrombin complex concentrate (PCC) can contain anticoagulant substances that may hamper their procoagulant effectiveness in the treatment of hemophilia B or reversal of oral anticoagulation, as well as the laboratory assessment thereof. The aim of the present study was to evaluate the influence of anticoagulant heparin supplement on the prohemostatic potential of different PCCs and FIX concentrates. MATERIALS AND METHODS: Prohemostatic potential was evaluated in vitro employing PT/aPTT, thrombography (TGA) and thromboelastography (TEG) with FIX deficient plasma, vitamin K antagonist (VKA)-anticoagulated plasma and plasma anticoagulated with rivaroxaban. RESULTS: Most PCCs contained heparin, while heparin was detected in 1 out of 4 examined FIX concentrates. All heparin-containing clotting factor concentrates showed severely hampered prohemostatic effects when therapeutic doses were added to anticoagulated plasmas. Upon heparin removal, comparable prohemostatic effects were observed. Of importance is the notion that the anticoagulant effect of heparin was enhanced by rivaroxaban, resulting in a 7 fold increased PT sensitivity towards heparin in the presence of 500µg/L rivaroxaban. CONCLUSIONS: Compositional differences between clotting factor concentrates should be taken into account. Therapeutic levels of heparin may be co-infused when treating emergency bleeds with high prohemostatic drug doses, particularly those recommended in the reversal of non-VKA anticoagulants such as rivaroxaban by PCC. Given the relative short half-life of heparin compared to vitamin K-dependent clotting factors, an anticoagulant heparin effect shortly after concentrate infusion should be considered clinically and while interpreting laboratory coagulation parameters.


Assuntos
Anticoagulantes/farmacologia , Fatores de Coagulação Sanguínea/farmacologia , Coagulação Sanguínea/efeitos dos fármacos , Coagulantes/farmacologia , Fator IX/farmacologia , Heparina/farmacologia , Anticoagulantes/análise , Fatores de Coagulação Sanguínea/análise , Testes de Coagulação Sanguínea , Coagulantes/análise , Combinação de Medicamentos , Fator IX/análise , Hemofilia B/tratamento farmacológico , Heparina/análise , Humanos
3.
J Sep Sci ; 34(3): 354-62, 2011 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-21268260

RESUMO

Cornu Rhinoceri Asiatici (rhinoceros horn, RH), Cornu Bubali (water buffalo horn, WBH), and Cornu Bovis grunniens (yak horn, YH) are traditional Chinese medicine (TCM), and have been used in China for thousands of years. In this study, ethnopharmacological experiments were used to evaluate and verify the traditional efficacies of horns. Area under curve (AUC) was used to quantify the pharmacological efficacy strength of three horns. Two-dimensional electrophoresis (2-DE) was used to analyze the protein components in horns, as a result, 14 common protein spots in rhinoceros horn, water buffalo horn, and yak horn electrophoresis gels were found by image analysis. Then linear regression analysis was used to establish the correlation between pharmacological efficacies and components in the horns, and five potential active components were selected from the 14 common protein spots. Finally, two protein spots from five were identified by matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS). In this study, a simple method to construct correlation between components and efficacy strength was explored by linear regression analysis, which could be applied to screen potential active components of animal horns.


Assuntos
Búfalos , Bovinos , Eletroforese em Gel Bidimensional/métodos , Cornos/química , Medicina Tradicional Chinesa , Proteínas/análise , Proteínas/farmacologia , Animais , Antipiréticos/análise , Antipiréticos/farmacologia , China , Coagulantes/análise , Coagulantes/farmacologia , Avaliação Pré-Clínica de Medicamentos , Etnofarmacologia , Feminino , Masculino , Espectrometria de Massas , Camundongos , Coelhos , Espectrometria de Massas por Ionização e Dessorção a Laser Assistida por Matriz
4.
J Immunol Methods ; 194(2): 121-9, 1996 Aug 14.
Artigo em Inglês | MEDLINE | ID: mdl-8765165

RESUMO

We wish to develop an in vitro test system for pyrogenic substances. A major source of pyrogen activity is endotoxin. Here we describe a highly sensitive endotoxin-monitoring system based on cytokine measurement in human cell lines of myelomonocytoid origin. The following measures were taken to develop an endotoxin monitoring system of high sensitivity. (i) Mono Mac 6 (MM6) and THP-1 cells, which both represent advanced stages of myelomonocytic development, were better suited as endotoxin indicators than the more immature U-937 line. (ii) In order to enhance cell surface expression of CD14, a major lipopolysaccharide (LPS) receptor, cells were pretreated for 2 days with calcitriol. (iii) The use of fetal calf serum (FCS) without detectable endotoxin traces was essential for maintaining a high LPS sensitivity. (iv) Selected subclones of either THP-1 or MM6 were significantly more sensitive LPS indicators than bulk cultures from which the clones originated. (v) Based on stimulation indices, a commercial tumor necrosis factor-alpha (TNF-alpha) immunoassay proved to be a more sensitive LPS indicator than other cytokine assays or the expression of procoagulant activity/tissue factor. Thus we were able to eliminate the disadvantage of previous cell line-based systems (i.e., low sensitivity) without loss of reproducibility which is seen when using fresh blood, monocytes or monocyte-derived macrophages. High endotoxin sensitivity is a prerequisite for a test system specifically indicating pyrogen activity, because it permits the testing of substances at higher dilutions, thereby minimizing nonspecific interference.


Assuntos
Endotoxinas/análise , Monócitos/citologia , Monócitos/efeitos dos fármacos , Calcitriol/farmacologia , Diferenciação Celular/efeitos dos fármacos , Diferenciação Celular/fisiologia , Divisão Celular/efeitos dos fármacos , Divisão Celular/fisiologia , Linhagem Celular , Coagulantes/análise , Coagulantes/farmacologia , Avaliação Pré-Clínica de Medicamentos/métodos , Humanos , Teste do Limulus , Lipopolissacarídeos/farmacologia , Macrófagos/citologia , Macrófagos/efeitos dos fármacos , Fenótipo , Pirogênios/análise , Reprodutibilidade dos Testes , Sensibilidade e Especificidade , Fator de Necrose Tumoral alfa/análise
5.
Carbohydr Res ; 263(1): 103-10, 1994 Oct 03.
Artigo em Inglês | MEDLINE | ID: mdl-7982225

RESUMO

The composition of the coagulant polysaccharide fraction from Strychnos potatorum seeds is described. This fraction comprises a 1:1.7 mixture of a galactomannan and a galactan. The structure of these polysaccharides is also discussed. In addition, the coagulant properties of the polysaccharide fractions of two other Strychnos species, innocua and nux-vomica, have been assayed.


Assuntos
Coagulantes/análise , Galactanos/análise , Mananas/análise , Plantas Medicinais/química , Polissacarídeos/análise , Sementes/química , Configuração de Carboidratos , Sequência de Carboidratos , Fracionamento Químico , Galactose/análogos & derivados , Dados de Sequência Molecular
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA